Welcome to our dedicated page for MetLife SEC filings (Ticker: MET), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The MetLife, Inc. (NYSE: MET) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, along with AI-supported tools to help interpret them. MetLife is a global financial services company offering insurance, annuities, employee benefits and asset management, with operations in more than 40 markets and leading positions in the United States, Asia, Latin America, Europe and the Middle East.
Investors can review current reports on Form 8-K, where MetLife discloses material events such as earnings announcements, segment reorganizations, acquisitions, reinsurance transactions and dividend declarations. Recent 8-K filings describe the designation of MetLife Investment Management (MIM) as a reportable segment, the reclassification of MetLife Holdings, the acquisition of PineBridge Investments, and a variable annuity reinsurance transaction with Talcott Resolution Life Insurance Company. Other 8-Ks address preliminary variable investment income information, preferred stock matters, and the company’s response to an unsolicited mini-tender offer.
Through this page, users can also locate quarterly and annual reporting materials referenced in MetLife’s filings, such as earnings releases, Quarterly Financial Supplements, total assets under management fact sheets and historical results supplements. These documents provide detail on segment performance across Group Benefits, Retirement and Income Solutions, regional insurance operations and MetLife Investment Management, as well as information on variable investment income and capital management.
Stock Titan’s platform enhances these filings with AI-powered summaries that explain key terms, highlight important changes and help clarify how specific disclosures may relate to MetLife’s broader business. Users can quickly identify items related to dividends, capital structure, segment changes, asset management acquisitions and risk transfer transactions without reading every line of each filing.
MetLife, Inc. filed a report showing a director acquired additional common stock as part of standard board compensation. On 01/02/2026, the director received 639 shares of MetLife common stock at a price of $80.32 per share, recorded as an acquisition. After this transaction, the director beneficially owned 8,064 shares held directly.
The company explains that non-management directors receive a portion of their retainer fees in MetLife common stock. In this case, the director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors, so the award reflects compensation rather than an open-market purchase.
MetLife, Inc. director reported receiving common stock as part of non-management director compensation on 01/02/2026. The filing shows an acquisition of 639 shares of MetLife common stock at $80.32 per share, bringing the director's directly held position to 45,415 shares. An additional 10 shares are reported as indirectly owned through the MetLife Policyholder Trust.
The company’s arrangements pay a portion of non-management director retainer fees in MetLife common stock, and the director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
MetLife, Inc. disclosed that one of its directors received 639 shares of MetLife common stock on 01/02/2026 as part of non‑management director compensation, at a reported price of $0 per share. After this grant, the director beneficially owned 18,080 shares of MetLife common stock in direct ownership. The company notes that its compensation arrangements pay a portion of non‑management director retainer fees in MetLife common stock rather than cash.
MetLife, Inc. reported a routine director equity compensation transaction. A non-management director acquired 639 shares of MetLife common stock on 01/02/2026 at $80.32 per share as part of the standard director retainer paid in stock. Following this transaction, the director beneficially owned 2,108 shares directly.
The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors, meaning the stock represents compensation that is being deferred rather than an open-market purchase.
MetLife, Inc. disclosed that one of its non-management directors received additional common stock as part of regular board compensation. On 01/02/2026, the director acquired 639 shares of MetLife common stock at a stated price of $0 per share, reflecting stock paid in lieu of a portion of cash retainer fees. Following this transaction, the director beneficially owns 33,990 shares of MetLife common stock in direct ownership. The filing notes that MetLife’s non-management director compensation arrangements provide that a portion of director retainer fees is paid in MetLife common stock.
MetLife, Inc. director Carlos M. Gutierrez reported receiving additional common stock as part of non-management director compensation. On 01/02/2026, he acquired 639 shares of MetLife common stock at a price of $0 per share, reflecting payment of a portion of his retainer fees in stock rather than cash. Following this transaction, he beneficially owns 25,024 shares directly and 18,807 shares indirectly through the Carlos M. Gutierrez Trust.
METLIFE, INC. reported that one of its directors acquired common stock as part of standard non-management director compensation. On 01/02/2026, the director received 639 shares of MetLife common stock at a price of $80.32 per share, recorded as an acquisition. After this transaction, the director beneficially owned 9,721 shares of MetLife common stock in direct ownership.
A portion of non-management director retainer fees is paid in MetLife common stock, and the director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. The filing is made by one reporting person in the capacity of a director.
MetLife, Inc. disclosed that one of its non-management directors acquired 639 shares of MetLife common stock on 01/02/2026 at a price of $80.32 per share. This transaction was reported as an acquisition related to the director's compensation.
After this transaction, the director beneficially owns 23,562 shares of MetLife common stock in direct ownership. The filing explains that MetLife's non-management director compensation includes payment of part of retainer fees in MetLife common stock, and the director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
MetLife, Inc. reported that one of its non-management directors acquired 1,105 shares of MetLife common stock on 01/02/2026 at a price of $80.32 per share. This was part of the standard director compensation program, under which portions of board and board chair retainers are paid in MetLife common stock rather than cash.
The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Following this transaction, the director beneficially owns 103,859 shares of MetLife common stock in direct ownership.
MetLife, Inc. reported a routine insider equity transaction involving one of its non-management directors. On 01/02/2026, the director received 639 shares of MetLife common stock as part of non-management director retainer fees, at a price of $80.32 per share. After this award, the director beneficially owned 4,931 shares of MetLife common stock held directly.
The filing notes that MetLife’s compensation arrangements pay a portion of non-management director fees in company stock, and the director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. This reflects standard equity-based compensation rather than an open-market purchase or sale.